The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index; none of the 25 sources its claims cite is checked for support yet.
Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited
Open accessAbstract
The sequential enzymatic actions of β-APP cleaving enzyme 1 (BACE1), presenilins (PS), and other proteins of the γ-secretase complex liberate β-amyloid (Aβ) peptides from larger integral membrane proteins, termed β-amyloid precursor proteins (APPs). Relatively little is known about the normal function(s) of APP or the neuronal compartment(s) in which APP undergoes proteolytic processing. Recent studies have been interpreted as consistent with the idea that APP serves as a kinesin-1 cargo receptor and that PS and BACE1 are associated with the APP-resident membranous cargos that undergo rapid axonal transport. In this report, derived from a collaboration among several independent laboratories, we examined the potential associations of APP and kinesin-1 using glutathione S-transferase pull-down and coimmunoprecipitation assays. In addition, we assessed the trafficking of membrane proteins in the sciatic nerves of transgenic mice with heterozygous or homozygous deletions of APP. In contrast to previous reports, we were unable to find evidence for direct interactions between APP and kinesin-1. Furthermore, the transport of kinesin-1 and tyrosine kinase receptors, previously reported to require APP, was unchanged in axons of APP-deficient mice. Finally, we show that two components of the APP proteolytic machinery, i.e., PS1 and BACE1, are not cotransported with APP in the sciatic nerves of mice. These findings suggest that the hypothesis that APP serves as a kinesin-1 receptor and that the proteolytic processing machinery responsible for generating Aβ is transported in the same vesicular compartment in axons of peripheral nerves requires revision.
Overview
CoChat Summary
TL;DR
This multi-laboratory study re-examined whether APP serves as a kinesin-1 cargo receptor and whether the APP processing machinery is cotransported in axons. It found no evidence for direct APP–kinesin-1 interaction or for cotransport of PS1/BACE1 with APP in mouse peripheral nerve, and axonal transport of kinesin-1 and Trk was unchanged in APP-deficient mice.
Key findings
- GST pull-down assays showed that TR-containing GST-KLC1 constructs bound GFP-AID, but also bound GFP alone, APLP1/APLP2 intracellular domains, Fe65, and PAT1a; in vitro-translated or heterologously expressed KLC1 did not bind GST-AID, whereas Fe65 and Numb did. The authors conclude the TR-domain binding is nonspecific and not evidence for a direct APP–kinesin-1 interaction.
- In mouse brain, APP did not cofractionate with kinesin-1: APP was primarily in V0/V1 fractions, whereas KHC and KLC were in all vesicle fractions including V2. APP also did not coimmunoprecipitate with multiple KHC or KLC antibodies, and kinesin-1 did not coimmunoprecipitate with APP antibodies; JIP3/SYD did coimmunoprecipitate with kinesin-1, with ~1% of total JIP3 cofractionating, validating the conditions.
- In sciatic nerves from 5-month-old wild-type, APP heterozygous knockout, APP homozygous knockout, and APPswe/Tg2576 mice, steady-state levels of KHC, dynein, synaptophysin, neurofilament, and β-tubulin were unchanged. After 24 h ligation, accumulation of KHC, KLC, Trk, and PS1 in proximal segments was comparable across APP genotypes, indicating APP-independent transport of kinesin-1 and Trk.
- PS1 was not cotransported with APP: after 6 h double ligation, APP accumulated proximal to the ligature, but PS1-NTF did not. BACE1 and Aβ were undetectable in sciatic nerve, including the proximal segment of APPswe mice, whereas BACE1 was detected as an ~70 kDa species in hippocampus and Aβ was detected in APPswe N2a cells and APPswe cortex.
Methods
- Six laboratories collaborated. The study used GST pull-down assays with recombinant KLC1, APP, APLP1, and APLP2 constructs plus in vitro transcription-translation; coimmunoprecipitation, immunodepletion, Western blotting, and vesicle fractionation from mouse brain.
- Mouse models included wild-type, APP heterozygous and homozygous knockout, APPswe/Tg2576, and BACE1-deficient mice, all at 5 months of age. Sciatic nerves were ligated for 6 or 24 h or crushed, and ~0.3 cm proximal and distal segments were analyzed by Western blot and immunohistochemistry.
- Main analyses were SDS-PAGE/Western blot, autoradiography, and confocal immunofluorescence; each presented experiment was repeated at least three times.
Limitations
- The paper states that APP and kinesin-1 could still interact indirectly through a linker protein such as JIP1b, but notes that such data are based only on in vitro analyses and need in vivo support.
- The paper states that secretases may be transported in axons at levels too low to detect, and that the findings in peripheral nerve may not apply to CNS neurons, where APP and secretase levels may be sufficient to generate Aβ.
- The paper considers it unlikely but acknowledges that abundant PS1 from cells intrinsic to the nerve could mask small amounts of axonally transported PS1; more broadly, the text makes evident that this is a negative/absence-of-detection study relying on antibody sensitivity and specificity, without live transport imaging or rescue experiments.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Kinesin-1 and APP do not cofractionate or coimmunoprecipitate from brain lysate. A , Subcellular fractionation of mouse brain was performed as described previously (Morfini et al., 2002) to generate three vesicle fractions (V0, V1, and V2) and a cytosolic fraction (Cyt). Under the conditions of fractionation, KHCs and KLCs are found in all fractions, but KLCs exhibit differences in stoichiometry and isoform composition. In contrast, APP immunoreactivity is associated primarily with V0 and V1 fractions, with only trace amounts in V2 and low levels in the cytosol. V2 contains high levels of KHC, KLC1, KLC2, synaptophysin (P38), and synapsin I. This suggests that kinesin-1 and APP do not cofractionate in mouse brain. B , Immunoprecipitates of kinesin-1 from mouse brain show that Coomassie blue-stained levels of kinesin-1 heavy chain are obtained (CB), but no band corresponding to APP was seen. Immunoblots of whole-brain lysate show that kinesin-1 heavy chain (H2) is readily resolved from APP (22C11) in this gel system. These are distinguishable even when a mixture of both antibodies (H2 + 22C11) is used for immunoblotting. C , Immunoprecipitation of kinesin-1 from mouse brain using antibodies against either kinesin-1 heavy chains (SUK4 or H2) or light chains (63-90, L1, L2, or KLC-All) precipitated both KHC and KLC subunits (Pfister et al., 1989; Stenoien and Brady, 1997). Nevertheless, APP could not be detected in immunoprecipitates using kinesin-1 antibodies. Brain lysate (L) was a positive control. Negative controls, i.e., protein G beads without primary antibodies (B) or with normal mouse IgG show immunoprecipitation specificity. Similarly, kinesin-1 subunits were not detectable in immunoprecipitates with APP antibodies [Ct-APP and JH; see KHC (H2) for kinesin-1 heavy chain, KLC (63-90) for kinesin-1 light chain]. Antigens in immunoprecipitates were visualized using specific antibodies against kinesin-1 subunits (H2 or 63-90) or APP (22C11 or Ct-APP). D , Immunoblot analysis showed detectable amounts of the scaffolding protein JIP3/SYD in kinesin-1 immunoprecipitates (H2 IPP). Conversely, anti-JIP3 antibodies (SYd IPP) coprecipitate small but detectable amounts of KHC. Immunoprecipitations with normal mouse (NM IPP) or normal rabbit (NR IPP) IgGs were used as negative controls. Note the relative levels of JIP3/SYD compared with original protein input. E , Immunodepletion of kinesin-1 and APP from mouse brain lysate exhibits different depletion patterns. Immunodepletion of KHC from lysate with H2 comparing IPs and corresponding supernatant samples shows a gradual reduction in the level of both KHC (H2) and KLC (63-90) in the pellet (lanes 1- 4) and the supernatant (lanes 13-16) after depletion cycles. In contrast, no change in APP level could be detected (Ct-APP, lanes 1- 4 and 13-16, respectively). Similarly, a reduction in APP level was observed after depletion using APP-specific antibodies AB5352 (Ct-APP, pellet, lanes 9 -12; supernatant, lanes 21-24), but no change in the level of kinesin-1 could be detected (KHC, lanes 9 -12, 21-24; KLC, lanes 9 -12, 21-24).](https://figures.cochat.ai/paper-figures/84cbabe77304476faa47cb0cdd869ba9/axonal-transport-amyloid-precursor-protein-kinesin-1-and-the-processing-figure-2.png)




Verification
Claims the paper makes
0 Valid · 0 Not valid · 21 Not checked · 123 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, biochemical and immunocytochemical assays show that neither PS1 nor BACE1 is cotransported with APP in sciatic nerves of mice.”
- Also stated in: § Abstract · boosted
“Finally, we show that two components of the APP proteolytic machinery, i.e., PS1 and BACE1, are not cotransported with APP in the sciatic nerves of mice.”
§ processing apparatus: revisited > Introduction
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Significantly, we demonstrate that axonal transport of kinesin-1 and tyrosine kinase (Trk) receptors are not altered in the absence of APP in APPϪ/Ϫ mice.”
- Also stated in: § Abstract · plain
“Furthermore, the transport of kinesin-1 and tyrosine kinase receptors, previously reported to require APP, was unchanged in axons of APP-deficient mice.”
§ processing apparatus: revisited > Introduction
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We show that recombinant fusion proteins containing various regions of either KLC1 or the cytoplasmic domains of APP can interact, but in a manner that is inconsistent with a specific association.”
§ processing apparatus: revisited > Introduction
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, endogenous APP did not cofractionate with kinesin-1 in membrane fractions or detergent homogenates prepared from mouse brain.”
§ processing apparatus: revisited > Introduction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but no apparent change in levels of APP in either pellet or supernatant fractions (Fig. 2 E, Ct-APP panel, lanes 1-4 and 13-16, respectively).”
§ processing apparatus: revisited > APP does not bind directly to kinesin-1
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
92 more claims
Create a free account to see all 144 claims and to verify the 20 references still open.
- It may state two separate claims as one. 34
- Probably not a substantial claim. 15
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ processing apparatus: revisited > APP does not bind directly to kinesin-1
“GST-KLC constructs containing only a subset of these repeats (GST-KLC-TR) pulled down similar levels of GFP-AID”
§ processing apparatus: revisited > Cloning of green fluorescent protein and glutathione S-transferase fusion proteins.
“the C terminus with all tandem repeats (amino acids 199 -444; KLC-TR)”
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Self-citationIdentification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P., Salbaum, J. M., Masters, C. L., & Beyreuther, K. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,239
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,064
Self-citationBorchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023
Self-citationAph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733
Self-citationβ-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
Zheng, H., Jiang, M., Trumbauer, M. E., Sirinathsinghji, D. J. S., Hopkins, R., Smith, D. W., Heavens, R. P., Dawson, G. R., Boyce, S., Conner, M. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90073-x · Cited by 704
Self-citationTanaka, Y., Kanai, Y., Okada, Y., Nonaka, S., Takeda, S., Harada, A., & Hirokawa, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81459-2 · Cited by 654
Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules
Verhey, K. J., Meyer, D., Deehan, R., Blenis, J., Schnapp, B. J., Rapoport, T. A., & Margolis, B. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.959 · Cited by 609
Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592 · cited 1×
“APP CTFs were likely to have been generated by -secretase processing of full-length APPswe in the trans-Golgi network (Haass et al., 1995).”
Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A., & Goldstein, L. S. B. (2001) · Nature · doi:10.1038/414643a · Cited by 583
MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 572
Self-citationKamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)00124-0 · Cited by 544
Morfini, G., Szebenyi, G., Elluru, R., Ratner, N., & Brady, S. T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.281 · Cited by 401
Self-citationKIF5C, a Novel Neuronal Kinesin Enriched in Motor Neurons
Kanai, Y., Okada, Y., Tanaka, Y., Harada, A., Terada, S., & Hirokawa, N. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06374.2000 · Cited by 334
Kinesin-Dependent Axonal Transport Is Mediated by the Sunday Driver (SYD) Protein
Bowman, A. B., Kamal, A., Ritchings, B. W., Philp, A. V., McGrail, M., Gindhart, J. G., & Goldstein, L. S. B. (2000) · Cell · doi:10.1016/s0092-8674(00)00162-8 · Cited by 331
Metabolism of the “Swedish” Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells
Thinakaran, G., Teplow, D. B., Siman, R., Greenberg, B., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9390 · Cited by 317
Self-citationThinakaran, G., Harris, C. L., Ratovitski, T., Davenport, F., Slunt, H. H., Price, D. L., Borchelt, D. R., & Sisodia, S. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28415 · Cited by 314
Self-citationLazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302 · cited 4×
“Several lines of evidence indicate that A is released at nerve terminals in the CNS (Lazarov et al., 2002; Sheng et al., 2002), but the neuronal compartments in which -secretase processing occurs have not been identified.”
InfluentialSelf-citationBuxbaum, J. D., Thinakaran, G., Koliatsos, V., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 293
Self-citationSisodia, S., Koo, E., Hoffman, P., Perry, G., & Price, D. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-07-03136.1993 · Cited by 284
Self-citationKaether, C., Skehel, P., & Dotti, C. G. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.4.1213 · Cited by 268
Pfister, K. K., Wagner, M. C., Stenoien, D. L., Brady, S. T., & Bloom, G. S. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.4.1453 · Cited by 258
Self-citationBrady, S. T., Pfister, K. K., & Bloom, G. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1061 · Cited by 236
Self-citationMarcinkiewicz, M., & Seidah, N. G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752133.x · Cited by 186
Matsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hirai, S., Ohno, S., Kita, Y., Kawasumi, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06597.2001 · Cited by 184
Hyperaccumulation of FAD-linked presenilin 1 variants in vivo
Lee, M. K., Borchelt, D., Kim, G. J., Thinakaran, G., Slunt, H. H., Ratovitski, T., Martin, L. J., Kittur, A., Gandy, S., Levey, A. I., et al. (1997) · Nature Medicine · doi:10.1038/nm0797-756 · Cited by 157
Self-citationAssociation of kinesin with characterized membrane‐bounded organelles
Leopold, P. L., McDowall, A. W., Pfister, K. K., Bloom, G. S., & Brady, S. T. (1992) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970230104 · Cited by 151
Self-citationImmunochemical analysis of kinesin light chain function
Stenoien, D. L., & Brady, S. T. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.4.675 · Cited by 143
Self-citationBACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo
Lee, E. B., Zhang, B., Liu, K., Greenbaum, E. A., Doms, R. W., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407070 · Cited by 140
Self-citationHilbich, C., Mönning, U., Grund, C., Masters, C. L., & Beyreuther, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74350-6 · Cited by 137
Elluru, R. G., Bloom, G. S., & Brady, S. T. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.1.21 · Cited by 129
Self-citationSheng, J. G., Price, D. L., & Koliatsos, V. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09794.2002 · Cited by 124 · cited 4×
“Several lines of evidence indicate that A is released at nerve terminals in the CNS (Lazarov et al., 2002; Sheng et al., 2002), but the neuronal compartments in which -secretase processing occurs have not been identified.”
InfluentialSelf-citationKim, S., Leem, J. Y., Lah, J. J., Slunt, H. H., Levey, A. I., Thinakaran, G., & Sisodia, S. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108245200 · Cited by 107
Self-citationRelease of Kinesin from Vesicles by hsc70 and Regulation of Fast Axonal Transport
Tsai, M.-Y., Morfini, G. A., Szebenyi, G., & Brady, S. T. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.6.2161 · Cited by 104
Self-citationDefective kinesin heavy chain behavior in mouse kinesin light chain mutants
Rahman, A., Kamal, A., Roberts, E. A., & Goldstein, L. S. B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1277 · Cited by 102 · cited 2×
“Nonetheless, KLC1 and KLC2 appear to be associated with different subsets of membrane-bound organelles (Leopold et al., 1992; Elluru et al., 1995; Stenoien and Brady, 1997; Rahman et al., 1999).”
Lamb, B. T., Bardel, K. A., Kulnane, L. S., Anderson, J. J., Holtz, G., Wagner, S. L., Sisodia, S. S., & Hoeger, E. J. (1999) · Nature Neuroscience · doi:10.1038/11154 · Cited by 102
Self-citationTu, P., Elder, G. A., Lazzarini, R. A., Nelson, D. L., Trojanowski, J. Q., & Lee, V. M. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.6.1629 · Cited by 88
Self-citationWard, B. M., & Moss, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2486-2493.2004 · Cited by 84
Shi, X.-P., Tugusheva, K., Bruce, J. E., Lucka, A., Wu, G.-X., Chen-Dodson, E., Price, E., Li, Y., Xu, M., Huang, Q., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209859200 · Cited by 70
Axonal transport and distribution of immunologically distinct kinesin heavy chains in rat neurons
Li, J., Pfister, K. K., Brady, S. T., & Dahlstr�m, A. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991015)58:2<226::aid-jnr3>3.0.co;2-x · Cited by 18
Self-citationApproaches to Study Interactions Between Kinesin Motors and Membranes
Morfini, G. A., Tsai, M.-Y., Szebenyi, G., & Brady, S. T. (2001) · Humana Press eBooks · doi:10.1385/1-59259-069-1:147 · Cited by 17
Self-citation(2002) · doi:10.1016/s0306-4522(02)00422-0
(2003) · doi:10.1016/j.biolcel.2003.10.004
(2002) · doi:10.1016/s0197-0186(02)00014-1
(2000) · doi:10.1006/nbdi.1999.0280
Self-citation
Research works printed but not linked: 1
- 2001, Methods Mol Biol, 164, 147
Cited by
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
“APP had been reported to function as a receptor for kinesin-1-mediated axonal transport (Kamal et al. 2000), but subsequent work has not confirmed the association of APP and kinesin-1 (Lazarov et al. 2005).”
BackgroundSelf-citationKinesin superfamily motor proteins and intracellular transport
Hirokawa, N., Noda, Y., Tanaka, Y., & Niwa, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2774 · Cited by 1,859
Axonal pathology in traumatic brain injury
Johnson, V. E., Stewart, W., & Smith, D. H. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.013 · Cited by 1,273
The axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,185
Metadata
- Authors
- Lazarov, O., Morfini, G. A., Lee, E. B., Farah, M. H., Szodorai, A., DeBoer, S. R., Koliatsos, V. E., Kins, S., Lee, V. M.-Y., Wong, P. C., Price, D. L., Brady, S. T., & Sisodia, S. S.
- Affiliations
- University of Chicago (US)
- University of Illinois Chicago (US)
- University of Pennsylvania (US)
- Johns Hopkins University (US)
- Heidelberg University (DE)
- Corresponding author
- Sisodia, Sangram S.
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-03-02
- Volume
- 25
- Issue
- 9
- Pages
- 2386-2395
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6726084
- OpenAlex
- W2161021536
- Cited by
- 239
- References
- 48
- Citations by year
- 2024: 4 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 3 · 2017: 1 · 2016: 8 · 2015: 12 · 2014: 20 · 2013: 13 · 2012: 20
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Ellison Medical Foundation
- Bristol-Myers Squibb Foundation
- Bristol-Myers Squibb
- Alzheimer Forschung Initiative
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (NS23868)
- National Institute on Aging (P01AG011542, R01AG021494, P50AG005146)
- National Institute of Neurological Disorders and Stroke (NS 23868, R01NS041438, R01NS023320, R01NS045150, R01NS041170, R01NS023868, R01NS043408, R56NS023868)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- amyloid precursor protein, kinesin-1, axonal transport, BACE1, presenilin 1, gamma-secretase, APP proteolytic processing, sciatic nerve, membrane protein trafficking, receptor tyrosine kinase
- MeSH terms
- Animals, Axons, Brain, Cloning, Molecular, Glutathione Transferase, Humans, Immunohistochemistry, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Endopeptidases, Protein Binding, Recombinant Fusion Proteins, Sciatic Nerve, Protein Biosynthesis, Blotting, Western, Gene Expression, Aspartic Acid Endopeptidases, Kinesins, Amyloid beta-Protein Precursor, Sciatic Neuropathy, Receptor Protein-Tyrosine Kinases, Protein Transport, Immunoprecipitation, Green Fluorescent Proteins, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.